Arasu Ganesan (A Ganesan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Pharmaceutics

Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Cancers

Molecules (Basel, Switzerland)

University of East Anglia

University of California Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of East Anglia

United Kingdom

Professor :: School of Pharmacy

University of Southampton

United Kingdom

Reader :: Chemistry

Institute of Molecular and Cell Biology

Singapore

Principal Investigator :: Combinatorial Chemistry

Institute of Molecular and Cell Biology

Singapore

Senior Research Chemist :: Centre for Natural Product Research

Harvard University

United States

Postdoctoral fellow :: Chemistry

Education History

University of California Berkeley

United States

PHD :: Chemistry

Publications

Maya Valmiki, Stephen Ping Teo, Pedro Ernesto de Resende, Simon Gibbons, Arasu Ganesan
Caudiquinol: A Meroterpenoid with an Intact C20 Geranylgeranyl Chain Isolated from Garcinia caudiculata . Molecules (Basel, Switzerland) 29 (15) (2024)
Meiling Le, Wenhua Lu, Xiaozhuo Tan, Bingling Luo, Tiantian Yu, Yameng Sun, Zhirong Guo, Peng Huang, Daqian Zhu, Qiang Wu, Arasu Ganesan, Shijun Wen
Design, Synthesis, and Biological Evaluation of Potent EZH2/LSD1 Dual Inhibitors for Prostate Cancer. Journal of medicinal chemistry (2024)
Maya Valmiki, Stephen Ping Teo, Pedro Ernesto de Resende, Simon Gibbons, Arasu Ganesan
Caudiquinol: A Meroterpenoid with an Intact C20 Geranylgeranyl Chain Isolated from Garcinia caudiculata . Molecules (Basel, Switzerland) 29 (15) (2024)
Patience Chihomvu, Arasu Ganesan, Simon Gibbons, Kevin Woollard, Martin A Hayes
Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation. International journal of molecular sciences 25 (16) (2024)
Patience Chihomvu, Arasu Ganesan, Simon Gibbons, Kevin Woollard, Martin A Hayes
Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation. International journal of molecular sciences 25 (16) (2024)
Anna Claudia Silva, Daniel Clemente de Moraes, Denilson Costa do Carmo, Giselle Cristina Casaes Gomes, Arasu Ganesan, Rosangela Sabbatini Capella Lopes, Antônio Ferreira-Pereira, Cláudio Cerqueira Lopes
Synthesis of Altissimacoumarin D and Other Prenylated Coumarins and Their Ability to Reverse the Multidrug Resistance Phenotype in Candida albicans . Journal of fungi (Basel, Switzerland) 9 (7) (2023)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Mohammed Aldholmi, Rizwan Ahmad, Daniel Carretero-Molina, Inmaculada Llamas, Jesús Martín, Fernando Reyes, Olga Genilloud, Léa Gourbeyre, Thierry Gefflaut, Hanne Carlsson, Alexei A Maklakov, Ellis O'Neill, Robert A Field, Barrie Wilkinson, Maria A O'Connell, Arasu Ganesan
Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga Euglena gracilis. Angewandte Chemie (International ed. in English) 61 (23) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
Paulo Eliandro da Silva Júnior, Shaiani Maria Gil de Melo, Murilo Helder de Paula, Ricardo Vessecchi, Jason Sirleaf, James E H Day, Arasu Ganesan, Flavio da Silva Emery
Growth vector elaboration of fragments: regioselective functionalization of 5-hydroxy-6-azaindazole and 3-hydroxy-2,6-naphthyridine. Organic & biomolecular chemistry 20 (37) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Ipek Bulut, Adam Lee, Ceyda Acilan, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, Arasu Ganesan, Ceyda Acilan
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers 14 (23) (2022)
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan Francisco Santibanez, Sheraz Gul, Milan Beljkas, Ana Đurić, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics 14 (12) (2022)
María Teresa Borrello, Hanae Benelkebir, Adam Lee, Chak Hin Tam, Manar Shafat, Stuart A Rushworth, Kristian M Bowles, Leon Douglas, Patrick J Duriez, Sarah Bailey, Simon J Crabb, Graham Packham, Arasu Ganesan
Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia. ChemMedChem 16 (8) (2021)
Timothé Maujean, Nicolas Girard, Arasu Ganesan, Mihaela Gulea, Dominique Bonnet
Three cheers for nitrogen: aza-DKPs, the aza analogues of 2,5-diketopiperazines. RSC advances 10 (71) (2020)
Vitor Coutinho Carneiro, Isabel Caetano de Abreu da Silva, Murilo Sena Amaral, Adriana S A Pereira, Gilbert Oliveira Silveira, David da Silva Pires, Sergio Verjovski-Almeida, Frank J Dekker, Dante Rotili, Antonello Mai, Eduardo José Lopes-Torres, Dina Robaa, Wolfgang Sippl, Raymond J Pierce, María Teresa Borrello, Arasu Ganesan, Julien Lancelot, Silvana Carvalho Thiengo, Monica Ammon Fernandez, Amanda Roberta Revoredo Vicentino, Marina Moraes Mourão, Fernanda Sales Coelho, Marcelo Rosado Fantappié
Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni. PLoS neglected tropical diseases 14 (7) (2020)
Mohammed Aldholmi, Barrie Wilkinson, Arasu Ganesan
Epigenetic modulation of secondary metabolite profiles in Aspergillus calidoustus and Aspergillus westerdijkiae through histone deacetylase (HDAC) inhibition by vorinostat. The Journal of antibiotics 73 (6) (2020)
Terence C S Ho, Alex H Y Chan, Arasu Ganesan
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. Journal of medicinal chemistry 63 (21) (2020)
Bertrand Lecointre, Remy Narozny, Maria Teresa Borrello, Johanna Senger, Alokta Chakrabarti, Manfred Jung, Martin Marek, Christophe Romier, Jelena Melesina, Wolfgang Sippl, Laurent Bischoff, Arasu Ganesan
Isoform-selective HDAC1/6/8 inhibitors with an imidazo-ketopiperazine cap containing stereochemical diversity. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 373 (1748) (2019)
Mohammed Aldholmi, Pascal Marchand, Isabelle Ourliac-Garnier, Patrice Le Pape, Arasu Ganesan
A Decade of Antifungal Leads from Natural Products: 2010-2019. Pharmaceuticals (Basel, Switzerland) 12 (4) (2019)
Arasu Ganesan
Epigenetic drug discovery: a success story for cofactor interference. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 373 (1748) (2019)
Arasu Ganesan
Epigenetics: the first 25 centuries. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 373 (1748) (2019)

Arasu Ganesan.css-eqlu8i{font-size:small;padding-left:4px;} (A Ganesan)

Publication Activity (10 Years)

Top Topics

Top Venues

Arasu Ganesan (A Ganesan)